Promore Pharma: A quarter characterized by preparatory work
Research Note
2018-08-20
17:18
Promore released their Q2 report this afternoon. Costs are in-line with expectations and the company is progressing towards starting the clinical trials with LL-37 and PXL01 during 2018.
MS
Mathias Spinnars
Disclosures and disclaimers